세계 화상 연고 시장 규모는 예측 기간인 2025-2032년 동안 5.95%의 CAGR로 2024년 10억 6,000만 달러에서 2032년 16억 8,000만 달러로 확대될 것으로 예상됩니다. 화상 연고 시장은 화상 치료 기술의 발전, 화상 관련 부상 증가, 연구 활동에 대한 관심 증가로 인해 성장할 것으로 예상됩니다. 미국 소방청에 따르면, 2023년 화재로 인한 부상률은 50-74세 연령층이 가장 높고, 5-9세 어린이가 가장 낮을 것으로 예상됩니다.
전 세계 화상 연고 시장은 주로 가정 내 사고 및 산업재해로 인한 화상 발생이 증가함에 따라 크게 성장하고 있습니다. 화상의 신속하고 적절한 관리의 필요성에 대한 국제적 인식이 높아짐에 따라 이러한 수요 증가는 더욱 강화되고 있습니다. 더 중요한 것은 지속적인 기술 혁신으로 인해 항균성, 이상적인 수분 수준, 재생 성분을 갖춘 매우 강력한 화상 연고가 개발되고 있으며, 천연 활성 성분과 허브 성분에 대한 소비자의 선호도가 변화하고 있다는 점입니다. 동시에, 특히 신흥 경제국에서 의료 시설의 발전과 발전, 접근성, 의료비 증가, 화상 치료 전문 센터의 성장으로 인해 고급 치료법이 더 널리 보급되고 있습니다. 최소한의 흉터와 기능 회복을 포함한 전인적 치유에 대한 관심 증가와 경미한 화상의 경우 자가 치료에 대한 소비자의 선호도가 높아짐에 따라 전 세계적으로 화상 연고 시장이 크게 성장하고 있습니다.
또한, 주요 연구 기관들은 환자 집단에 제공되는 치료의 질을 향상시키기 위해 새로운 기술 개발에 주력하고 있습니다. 예를 들어, 2023년 12월 International Immunopharmacology에 게재된 논문에 따르면, 연구팀은 깊은 화상의 치유를 촉진하기 위해 bFGF와 VEGFA 유전자를 포함하는 혈소판막 생체모방 나노입자를 도입했습니다. NP 복합체는 투여 시 화상 상처를 효율적으로 표적으로 삼았습니다. 쥐에게 PM& 유전자-NP 복합체를 투여한 결과, 화상 상처의 관류가 촉진되고 치유도 대조군에 비해 빠르게 진행되었습니다.
세계의 화상 연고 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 화상 심도별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 전해드립니다.
Global burn ointment market is projected to witness a CAGR of 5.95% during the forecast period 2025-2032, growing from USD 1.06 billion in 2024 to USD 1.68 billion in 2032. The burn ointment market is expected to grow due to advancements in burn treatment technologies, increasing incidences of burn-related injuries, and rising focus on research activities. According to the United State Fire Administration, individuals between the ages of 50-74 had the highest fire injury rates and children between 5 and 9 years old the lowest rate of fire injury in 2023.
The global market for burn ointment has seen significant growth, driven chiefly by the rising worldwide prevalence of burn injuries through domestic accidents, and industrial accidents, among others. This enhanced requirement is further reinforced by a greater international awareness of the overriding need for the quick and proper management of burns. More importantly, ongoing technical innovations have resulted in the development of highly potent burn ointment with advanced antimicrobial properties, ideal moisture levels, and regenerative elements as well as a shifting preference on the part of consumers for naturally active and herbal elements. At the same time, the development and advancement of healthcare facilities and accessibility, especially in developing economies, as well as rising healthcare expenditure and growth in specialized burn care centers, are facilitating wider accessibility of advanced forms of treatment. Increasing focus on holistic healing involving minimum scarring and functional restoration and increased consumer preference for self-care in mild burn injury instances, all underpin the extensive growth in the market for burn ointment on a worldwide scale.
Additionally, leading research organizations are focusing on developing new technologies to improve the quality of care provided to the patient population. For instance, according to an article published in International Immunopharmacology in December 2023, a team of researchers introduced Biomimetic nanoparticles of the platelet membranes containing bFGF and VEGFA genes to enhance the healing of deep burn wounds. The PM@gene-NP complexes targeted the burn wounds efficiently upon their administration. The rats showed enhanced perfusion of the burn wounds as well as their faster healing compared to control groups after administration of the PM@gene-NP complexes.
Technology Advancement in Burn Care to Fuel the Market Demand for Burn Ointment
Technological progress has significantly changed burn care from a matter of simply enduring to making a big difference in patient outcomes and quality of life. Some of the important breakthroughs involve the evolution of hydrogel-based dressings and bioengineered skin replacements which promote optimum healing and diminish the requirement for autografts and advanced imaging techniques for accurate assessment of wounds. Nanotechnology and regenerative medicine hold promises of better infection control and faster tissue regeneration, and virtual reality holds the promise of non-pharmacological pain relief while caring for wounds. Additionally, critical care support has decreased mortality appreciably and novel laser innovations are redefining scar management, all contributing toward less painful, less traumatic and better cosmetically acceptable healing of burn injuries.
Various research and medical institutes across the globe are also focusing on the development of ointments that prevent partial thickness burns. For instance, the Vanderbilt University Medical Center is conducting an interventional study for investigating the efficacy and safety of an immunosuppressive agent (tacrolimus ointment) in patients suffering from deep partial-thickness burns. The study is estimated to conclude in December 2026.
Rising Cases of Fire Injury Boost Market Demand
The rising cases of fire injury resulting from domestic accidents, industrial hazards, road mishaps, and fire related incidents continuously boost the demand for effective burn care products. This trend is particularly prominent in low and middle-income countries, where infrastructure and safety protocols are often inadequate. As a result, there is a growing need for advanced burn ointments that promote faster healing, reduce infection risk, and improve patient outcomes. To decrease the fire injury cases the government also takes the initiative to promote safety precautions, quick fire exits practices by launching campaigns and fire exits programs. As per National Fire Protection Associations (NFPA) in 2023 about 1.39 million fires were responded to by local fire departments in the United States. An estimated 3,670 civilian fire fatalities and 13,350 civilian fire injuries resulted from these fires. Property losses due to these fires were about USD 23 billion.
Hospitals to Hold Major Market Share in the Burn Ointment Market
Hospitals command huge market share in the burn ointment market owing to several key factors. First, they remain the initial focal point of care for serious to critical burn injuries calling for specialized care in many instances involving a multi-specialty team as well as sophisticated facilities such as burn centers. Such serious injuries call for a volume and range of advanced burn ointments as well as prescription strengths and novel bioengineered skin constructs. Second, they enjoy bulk purchasing contracts and government-sponsored healthcare programs, whereby they can access the latest formulations at competitive prices. Thirdly, hospitals tend to be the initial adopters and pioneers of clinical innovations in the form of introducing them into clinical practice before they become mainstream available to consumers. And lastly, the prevalence of serious burn injuries calling for professional medical treatment and the inherent challenges in dealing with extensive burn wounds as well as infection prevention and healing stimulate the hospital segment's dominance in the burn ointment market. Additionally, to ensure that patients with burn injuries receive proper care and treatment, hospitals across the globe are focusing on adding separate burn wards. For instance, in May 2025, Bheri Hospital, Nepalgunj, Nepal established a burn ward with 6 beds and 14 beds surgical wing in its new building.
North America Dominates the Burn Ointment Market
North America is exerting its dominance in the burn ointment market. This region boasts well established healthcare systems, including specialized burn centers and hospital equipment with advanced and modern treatment facilities, including organization such as American Burn Association (ABA) and American College of Surgeon. The government and non-government organizations are increasing awareness and prevention by launching campaigns and spreading knowledge of first aid for burns, leading to improved access to quick burn treatment. Additionally, North America also has a strong presence of pharmaceutical and medical companies such as Johnson & Johnson Services, Inc., 3M Company and Pfizer Inc., which ensures steady product innovation, availability and marketing. For instance, in April 2025, AVITA Medical, Inc. presented 16 abstracts that showcased groundbreaking data related to wound and burn care at the American Burn Association (ABA) 2025 Annual Meeting in Arizona, United States.
Impact of U.S. Tariffs on Burn Ointment Market
U.S. tariffs have major implications for the global burn ointment market as they are raising costs of production and prices because of tariffs imposed on raw materials and final products. This creates supply chain breakdowns, which drive manufacturers to consider reshoring or nearshoring to enhance resilience at the expense of higher accompanying costs. Businesses also turn to stockpiling, which impacts inventory management. In the long run, such tariffs can restrict access and affordability of burn ointments, causing a change in global trade patterns and potentially affecting access to healthcare.
Key Players Landscape and Outlook
The worldwide burn ointment market has an intense rivalry between established medical and drug companies as well as innovative niche players. Dominant players utilize research and development efforts for innovative formulations in the form of biologics and nanotechnology and strategic acquisitions in a bid to gain market coverage and enhance portfolios. There's also increased emphasis on herbal and natural ingredients in a bid to address consumer demand. The outlook for the market remains optimistic on account of increasing burn injuries and ongoing advancements in wound care. Future directions involve ongoing development of regenerative therapies to reduce scarring and expansion of the biologics segment. The market will experience continued expansion through innovation, strategic alliances, and a shift toward delivering enhanced and easy burn care solutions.
Additionally, players are also focusing on launching new products. For instance, in March 2024, Integra Life Sciences Corporation introduces Micro Matrix Flex to make it easy to access hard-to-reach areas in complex procedures. Integra's UBM products - including Micro Matrix UBM Particulate and Cytal Wound Matrix sheets - have been used in more than 360,000 procedures over the past decade. This development resulted from close collaboration with surgeons to address significant treatment challenges and establish a new level of care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.